Becton, Dickinson and Co. launched Effivax, a glass prefillable syringe, “to meet the complex and evolving needs of vaccine manufacturing,” the medtech company said Sept. 13.
President Joe Biden signed an executive order Sept. 12 to reinforce domestic manufacturing capabilities because the U.S. “has relied too heavily on foreign materials and bioproduction.”
As natural disasters become more frequent with climate change, experts say the supply chain crisis could also be exacerbated with increased shortages, delayed deliveries and higher prices, The New York Times reported Sept. 8.
Medline, a supply distributor based in Northfield, Ill., devoted half a billion dollars to its efforts to “ensure product availability and timely delivery” of medical products.
It’s been a bumpy road for monkeypox vaccines between 28 million doses expiring in 2017 and demand outpacing manufacturing capacity, but the pavement seems to be smoothing out after months of problems.